These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 95493)

  • 21. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of ketazone in otorhinolaryngology].
    Traissac L; Chabrol A
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(5-6):341-7. PubMed ID: 1101334
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperfractionated irradiation with cobalt 60 in ORL cancers].
    Legros M; Castera D; Longuebray A; Blondel JH
    Ann Otolaryngol Chir Cervicofac; 1978 Mar; 95(3):205-10. PubMed ID: 666222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Teicoplanin in the treatment of otorhinolaryngologic infections (ORL) caused by gram-positive organisms].
    Mosconi G; Pugnetti P; Bachini V
    G Ital Chemioter; 1991; 38(1-3):165-6. PubMed ID: 1365580
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
    Baumgartner G
    Wien Klin Wochenschr; 1973 Oct; 85(42):686-92. PubMed ID: 4128921
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion.
    Krakoff IH; Cvitkovic E; Currie V; Yeh S; LaMonte C
    Cancer; 1977 Nov; 40(5):2027-37. PubMed ID: 72595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of polychemotherapy (bleomycin-cisplatin type) in epidermoid carcinomas of the ORL field in stages T3 or T4; 1st intention or palliative chemotherapy].
    Rebattu JP; Michalet JF; Guyon JM; Colin B
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1983 Apr; 32(4):251-5. PubMed ID: 6190984
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of Ponstan in otorhinolaryngologic diseases].
    Castelli G
    Schweiz Rundsch Med Prax; 1973; 62(30):946-8. PubMed ID: 4378387
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trial of Bacampicine].
    Morgon A
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Jan; 30(1):55-8. PubMed ID: 6450821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trial of a new bactericide: Quam, in infectious otorhinolaryngologic pathology].
    Dubreuil C; Pignal JL
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Nov; 30(9):615-8. PubMed ID: 6459426
    [No Abstract]   [Full Text] [Related]  

  • 31. [Superweak radiation of tumors or the ORL region].
    Navrátil J
    Acta Univ Palacki Olomuc Fac Med; 1983; 104():301-6. PubMed ID: 6222614
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G
    Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720
    [No Abstract]   [Full Text] [Related]  

  • 33. [The clinical efficacy of cefsulodin to the infection of otorhinolaryngological field].
    Baba S; Maruo T; Sasaki T; Miyano K; Maruyama H; Miyake H; Sakai M; Fujii K; Saito N; Takimoto I; Inafuku S; Nomura T; Yamashita K; Sato K; Ogawa A; Ueda T; Yoshizumi T; Nakai Y; Sugiyama M; Ohashi Y; Goto K; Ohta F; Murata K; Boku S; Miyamae M; Yonei K; Harada Y; Yajin K; Chikuie D; Hirata K
    Jpn J Antibiot; 1982 Dec; 35(12):2851-60. PubMed ID: 6763636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preoperative adjuvant chemotherapy in epidermoid carcinoma of the otorhinolaryngologic region].
    Kappauf H; Theissing J
    Dtsch Med Wochenschr; 1981 Apr; 106(15):451-2. PubMed ID: 6163601
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical use of dexamethasone (Dectan) in otorhinolaryngology].
    Sato M; Hayakawa T; Abe K; Iwama S; Takeyama I
    Jibiinkoka; 1966 May; 38(5):549-55. PubMed ID: 5336147
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions.
    Shingaki S; Kawasaki T; Nagamine T; Kanamaru T; Yokobayashi T; Nakajima T
    J Oral Surg; 1980 Dec; 38(12):886-92. PubMed ID: 6160232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
    Fries R; Wilfert KH
    Osterr Z Erforsch Bekampf Krebskr; 1973; 28(1):29-32. PubMed ID: 4123658
    [No Abstract]   [Full Text] [Related]  

  • 38. [Double-blind study of a vasoregulating agent in vascular manifestations in otorhinolaryngology].
    Lacaze JL; Bébéar JP
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(1-2):93-8. PubMed ID: 788083
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of Foncitril 4000 in combination with antibiotictherapy in clinical E.N.T. practice].
    Gaillard de Collogny L; Verge P
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):655-60. PubMed ID: 4280430
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of epitheliomas of the otorhinolaryngological and cervicofacial area using bleomycin].
    Leroux-Robert J; Graverol MT; Villedrouin J
    Ann Otolaryngol Chir Cervicofac; 1972; 89(4):201-18. PubMed ID: 4116540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.